文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 药学 > Population Pharmacokinetics and Proton Pump Inhibitory Effects of_pdf.
侵权投诉

Population Pharmacokinetics and Proton Pump Inhibitory Effects of_pdf.

2238Biol. Pharm. Bull.30(12) 2238—2243 (2007)Vol. 30, No. 12

Population Pharmacokinetics and Proton Pump Inhibitory Effects ofIntravenous Lansoprazole in Healthy Japanese Males

Yuichi SAKURAI,a,bMasashi HIRAYAMA,bMuneaki HASHIMOTO,bTakanori TANAKA,cSetsuo HASEGAWA,dShin IRIE,eKiyoshi ASHIDA,fYuichiro KAYANO,aMasato TAGUCHI,aand Yukiya HASHIMOTO*,a

Graduate School of Pharmaceutical Sciences, University of Toyama; 2630 Sugitani, Toyama 930–0194, Japan: bTakedaPharmaceutical Company Limited; 4–1–1 Dosyo-machi, Chuo-ku, Osaka 540–8645, Japan: cOhsaki Clinic; 5–7–13Kitashinagawa, Shinagawa-ku, Tokyo 141–0001, Japan: dSekino Clinical Pharmacology Clinic; 3–28–3 Ikebukuro,Toshima-ku, Tokyo 171–0014, Japan: eKyushu Clinical Pharmacology Research Clinic; 2–13–16 Jigyo, Chuo-ku, Fukuoka810–0064, Japan: andfSaiseikai Nakatsu Hospital; 2–10–39 Shibata, Kita-ku, Osaka 530–0012, Japan.Received June 20, 2007; accepted September 18, 2007

A total of 56 healthy Japanese males were enrolled in single- or multiple- dose pharmacokinetic trials of in-travenous lansoprazole administration. The population pharmacokinetics of the drug was evaluated using non-linear mixed effects model (NONMEM) software. In addition, the effect of CYP2C19 polymorphism on protonpump inhibition by lansoprazole was investigated using 24-h intragastric pH monitoring in the 32 subjects. Timecourse of serum lansoprazole concentration following intravenous short infusion was well described by a 2-com-partment model. The mean volume of the central and peripheral compartments was 0.110 and 0.201l/kg, respec-tively. The mean inter-compartment clearance was estimated to be 0.0882l/h/kg. The population mean value ofsystemic clearance in the homoEM (CYP2C19*1/*1), heteroEM (CYP2C19*1/*2and *1/*3), and PM(CYP2C19*2/*2, *2/*3, and *3/*3) groups was 0.179, 0.109, and 0.038l/h/kg, respectively. The mean intragastricpH following twice-daily doses of 30mg lansoprazole was approximately 6, 5, and 4 in the PM, heteroEM, andhomoEM groups, respectively. These ndings indicate that large interindividual variability exists in the pharma-cokinetics of intravenously administered lansoprazole, but that twice-daily infusion of a 30mg dose leads to sig-ni cant and sustained proton pump inhibition, even in the homoEM group, despite the short elimination half-lifeof the drug.

Key words

lansoprazole; population pharmacokinetics; healthy Japanese subject; CYP2C19

a

Upper gastrointestinal bleeding is one of the commoncauses of emergency hospital admission in Japan, and it pos-sibly results in life-threatening massive hemorrhage. Endo-scopic clipping of the bleeding vessel is usually effective fortreating gastrointestinal hemorrhage, but rebleeding occurs in15 to 20% of patients.1)Higher intragastric pH promotesplatelet aggregation, and the inhibition of gastric acid secre-tion to maintain neutral pH may stabilize clots and preventrecurrent bleeding.2)Intravenous administration of histamineH2-receptor antagonists has been widely used for the man-agement of gastrointestinal hemorrhage, particularly after en-doscopic clipping. However, gastric acid secretion is notsolely regulated by the histamine H2-receptor, and toleranceto the antisecretory activity of H2-receptor antagonists fre-quently develops during infusion over 72-h periods, leadingto a loss of pH control.1,3)Meta-analyses have also suggestedthat H2-receptor antagonists only have a weak bene cial ef-fect.4)On the other hand, proton-pump inhibitors (PPIs) sup-press gastric acid secretion by speci c inhibition of theH /K ATPase enzyme system located on the secretory sur-face of gastric parietal cells.5—7)High doses of PPIs maintainthe intragastric pH at a nearly neutral level, and inhibit acidproduction more effectively than an infusion of H2-receptorantagonists.3,8)Therefore, high-dose intravenous PPI therapyis theoretically superior to intravenous H2-receptor antagonisttherapy for the prevention of recurrent bleeding. In fact, sev-eral studies have indicated that intravenous administration ofPPIs is effective for the treatment of patients with gastroin-testinal bleeding.1,4,9,10)

It has been reported that PPIs (omeprazole and lansopra-zole) are mainly metabolized by cytochrome P450 (CYP)

To whom correspondence should be addressed.

2C19.11,12)The genetic polymorphisms of CYP2C19 havebeen observed in Asian populations, and three polymor-phic alleles, CYP2C19*1(wild-type), CYP2C19*2, andCYP2C19*3, have been identi ed among Japanese.13)CYP2C19*2causes a splicing defect in exon 5, andCYP2C19*3creates a premature stop codon in exon 4.13)Therefore, these mutations lead to the complete loss of theenzymatic activity of CYP2C19. The allele frequencies ofCYP2C19*2and CYP2C19*3among Japanese are reportedto be 28.7% and 13.2%, respectively.14)It has been reportedthat genetic polymorphisms of CYP2C19 are responsible forthe large interindividual variability in the pharmacokineticsof orally administered PPIs in Japanese populations.15,16)

Recently, a new preparation for intravenous injection oflansoprazole was developed in Japan. In the present study,we evaluated the population pharmacokinetics of intra-venously administered lansoprazole in healthy Japanese sub-jects using a nonlinear mixed effects model (NONMEM)program. We also evaluated the effect of CYP2C19 polymor-phisms on proton pump inhibition by intravenously adminis-tered lansoprazole.

MATERIALS AND METHODS

SubjectsA total of 56 healthy Japanese adult male vol-unteers participated in this study. All of the subjects werecon rmed to be healthy on the basis of their medical history,physical ndings, laboratory studies, and 12-lead electrocar-diogram. The subjects ranged in age from 20 to 34 (mean S.D.: 24.0 4.0) years old, and their weight ( S.D.) was61.8 6.0kg. The subjects were classi ed into three groups

© 2007 Pharmaceutical Society of Japan

e-mail: yukiya@pha.u-toyama.ac.jp

第1页

你可能喜欢

热门文档

相关文档

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email